Similar articles

• Combined in vivo depletion of glycoprotein VI and C-type lectin-like receptor 2 severely compromises hemostasis and abrogates arterial thrombosis in mice.

  Bender M, May F, Lorenz V, Thielmann I, Hagedorn I, Finney BA, Vögtle T, Remer K, Braun A, Bösl M, Watson SP, Nieswandt B. Bender M, et al. Arterioscler Thromb Vasc Biol. 2013 May;33(5):926-34. doi: 10.1161/ATVBAHA.112.300672. Epub 2013 Feb 28. Arterioscler Thromb Vasc Biol. 2013. PMID: 23448972 Free PMC article.
• Podoplanin-expressing inflammatory macrophages activate murine platelets via CLEC-2.

  Kerrigan AM, Navarro-Nuñez L, Pyz E, Finney BA, Willment JA, Watson SP, Brown GD. Kerrigan AM, et al. J Thromb Haemost. 2012 Mar;10(3):484-6. doi: 10.1111/j.1538-7836.2011.04614.x. J Thromb Haemost. 2012. PMID: 22212362 Free PMC article. No abstract available.
• Targeting glycoprotein VI and the immunoreceptor tyrosine-based activation motif signaling pathway.

  Stegner D, Haining EJ, Nieswandt B. Stegner D, et al. Arterioscler Thromb Vasc Biol. 2014 Aug;34(8):1615-20. doi: 10.1161/ATVBAHA.114.303408. Epub 2014 Jun 12. Arterioscler Thromb Vasc Biol. 2014. PMID: 24925975 Review.
• Anti-glycoprotein VI treatment severely compromises hemostasis in mice with reduced alpha2beta1 levels or concomitant aspirin therapy.

  Grüner S, Prostredna M, Aktas B, Moers A, Schulte V, Krieg T, Offermanns S, Eckes B, Nieswandt B. Grüner S, et al. Circulation. 2004 Nov 2;110(18):2946-51. doi: 10.1161/01.CIR.0000146341.63677.3C. Epub 2004 Oct 25. Circulation. 2004. PMID: 15505105
• Snaclecs (snake C-type lectins) that inhibit or activate platelets by binding to receptors.

  Clemetson KJ. Clemetson KJ. Toxicon. 2010 Dec 15;56(7):1236-46. doi: 10.1016/j.toxicon.2010.03.011. Epub 2010 Mar 27. Toxicon. 2010. PMID: 20350564 Review.